Thursday, May 23, 2019
wellness India Expo
Home Tags CDSCO

Tag: CDSCO

Govt notifies new medtech rules, industry bodies give mixed reactions

While the categorization of medical technology as a separate industry has been widely hailed by the industry bodies yet the new medical device rules notified by government has left them unsatisfied

BioVoice eMag December 2016 – January 2017 Issue-8 Volume-1

BioVoice eMag December 2016 - January 2017 Issue-8 Volume-1: This edition of BioVoice features detailed cover story on demonetization move and the immediate steps taken...

DCGI simplifies regulatory processes for vaccine & r-DNA products

While streamlining the issuance of Form 29 licenses, the Drug Controller General of India has also removed the need for joint inspections of vaccines and r-DNA products....

Shortage of life saving drugs, govt monitoring situation

Amid complaints over shortage of D-Pencillamine, the health ministry has initiated action on the same and these are being forwarded....

Applications for grant of NOCs for BA/BE studies made ‘online only’...

As a part of its e-governance initiatives, the clinical research regulator will accept only online application from 13 September 2016 for issue of NOCs.....

Leading MedTech companies launch Medical Technology Association of India (MTaI)

Founded in India with an aim to accelerate the growth of medical technology sector, this association mainly represents multinational companies......

AIMED welcomes govt’s advisory on domestic standards for procuring medical devices

The association of Indian medical devices industry has stated that the move will create fair parity between domestically......

Industry welcomes CDSCO’s circular on investigators & sites

The Central Drugs Standard Control Organization's decision reflects the views of most of the stakeholders, mentioned the Indian Society for.......

DCGI revises its 50 bed hospital, 3 clinical trials per investigator...

The Drug Controller General of India has finally decided to revise the earlier move that made maximum 3 trials per investigator....

Revised ‘India specific’ biosimilar guidelines expected soon

While the 'Biosimilar Guidelines' adopted in 2012 have been well appreciated, there was an overall sentiment ...